influenza ha antigen
Vaccineexperimental
Clinical trial activity
4 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2012 (NCT01623232)
Timeline
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- influenza ha antigen
- influenza ha vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03437304 | Phase 1/Phase 2 (Phase 2) | Feb 9, 2018 | Clinical Trial Consultants AB, Eurocine Vaccines AB |
| NCT02555618 | Phase 2 | Sep 1, 2015 | Takeda |
| NCT03293732 | Phase 1 | Nov 28, 2012 | Advagene, National Taiwan University |
| NCT01623232 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2012 | Department of Veteran Affairs, St. Louis University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Advagene | For profit | 1 | 1 | 1 | 2012 |
| Clinical Trial Consultants AB | For profit | 1 | 0 | 1 | 2018 |
| Department of Veteran Affairs | Government | 1 | 1 | 1 | 2012 |
| Eurocine Vaccines AB | For profit | 1 | 1 | 1 | 2018 |
| National Taiwan University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| St. Louis University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Takeda | For profit | 1 | 1 | 1 | 2015 |
7 organizations
Page 1 / 1